BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019;16:690-704. [PMID: 31554963 DOI: 10.1038/s41575-019-0209-8] [Cited by in Crossref: 164] [Cited by in F6Publishing: 150] [Article Influence: 54.7] [Reference Citation Analysis]
Number Citing Articles
1 Galan-Ros J, Ramos-Arenas V, Conesa-Zamora P. Predictive values of colon microbiota in the treatment response to colorectal cancer. Pharmacogenomics 2020;21:1045-59. [PMID: 32896201 DOI: 10.2217/pgs-2020-0044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ferrari A, Neefs I, Hoeck S, Peeters M, Van Hal G. Towards Novel Non-Invasive Colorectal Cancer Screening Methods: A Comprehensive Review. Cancers (Basel) 2021;13:1820. [PMID: 33920293 DOI: 10.3390/cancers13081820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Spatz M, Richard ML. Overview of the Potential Role of Malassezia in Gut Health and Disease. Front Cell Infect Microbiol 2020;10:201. [PMID: 32528901 DOI: 10.3389/fcimb.2020.00201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
4 Cheng Y, Ling Z, Li L. The Intestinal Microbiota and Colorectal Cancer. Front Immunol 2020;11:615056. [PMID: 33329610 DOI: 10.3389/fimmu.2020.615056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
5 Duan Y, Young R, Schnabl B. Bacteriophages and their potential for treatment of gastrointestinal diseases. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34782783 DOI: 10.1038/s41575-021-00536-z] [Reference Citation Analysis]
6 Zhu C, Gong H, Luo P, Dong L, Zhang G, Shi X, Rong W. Oral Administration of Penicillin or Streptomycin May Alter Serum Serotonin Level and Intestinal Motility via Different Mechanisms. Front Physiol 2020;11:605982. [PMID: 33424630 DOI: 10.3389/fphys.2020.605982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Knippel RJ, Drewes JL, Sears CL. The Cancer Microbiome: Recent Highlights and Knowledge Gaps. Cancer Discov 2021;11:2378-95. [PMID: 34400408 DOI: 10.1158/2159-8290.CD-21-0324] [Reference Citation Analysis]
8 Miao Y, Li Q, Wang J, Quan W, Li C, Yang Y, Mi D. Prognostic implications of metabolism-associated gene signatures in colorectal cancer. PeerJ. 2020;8:e9847. [PMID: 32953273 DOI: 10.7717/peerj.9847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
9 Li J, Zuo K, Zhang J, Hu C, Wang P, Jiao J, Liu Z, Yin X, Liu X, Li K, Yang X. Shifts in gut microbiome and metabolome are associated with risk of recurrent atrial fibrillation. J Cell Mol Med 2020;24:13356-69. [PMID: 33058365 DOI: 10.1111/jcmm.15959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bakuradze N, Merabishvili M, Makalatia K, Kakabadze E, Grdzelishvili N, Wagemans J, Lood C, Chachua I, Vaneechoutte M, Lavigne R, Pirnay JP, Abiatari I, Chanishvili N. In Vitro Evaluation of the Therapeutic Potential of Phage VA7 against Enterotoxigenic Bacteroides fragilis Infection. Viruses 2021;13:2044. [PMID: 34696475 DOI: 10.3390/v13102044] [Reference Citation Analysis]
11 Li Z, Wang Y, Liu J, Rawding P, Bu J, Hong S, Hu Q. Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy. Adv Mater 2021;:e2102580. [PMID: 34347325 DOI: 10.1002/adma.202102580] [Reference Citation Analysis]
12 Wang T, Zhang L, Wang P, Liu Y, Wang G, Shan Y, Yi Y, Zhou Y, Liu B, Wang X, Lü X. Lactobacillus coryniformis MXJ32 administration ameliorates azoxymethane/dextran sulfate sodium-induced colitis-associated colorectal cancer via reshaping intestinal microenvironment and alleviating inflammatory response. Eur J Nutr 2021. [PMID: 34185157 DOI: 10.1007/s00394-021-02627-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Guo C, Guo D, Fang L, Sang T, Wu J, Guo C, Wang Y, Wang Y, Chen C, Chen J, Chen R, Wang X. Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon. Carbohydr Polym 2021;267:118231. [PMID: 34119183 DOI: 10.1016/j.carbpol.2021.118231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lin Y, Wang G, Yu J, Sung JJY. Artificial intelligence and metagenomics in intestinal diseases. J Gastroenterol Hepatol 2021;36:841-7. [PMID: 33880764 DOI: 10.1111/jgh.15501] [Reference Citation Analysis]
15 Parker KD, Maurya AK, Ibrahim H, Rao S, Hove PR, Kumar D, Kant R, Raina B, Agarwal R, Kuhn KA, Raina K, Ryan EP. Dietary Rice Bran-Modified Human Gut Microbial Consortia Confers Protection against Colon Carcinogenesis Following Fecal Transfaunation. Biomedicines 2021;9:144. [PMID: 33546192 DOI: 10.3390/biomedicines9020144] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhou Z, Ge S, Li Y, Ma W, Liu Y, Hu S, Zhang R, Ma Y, Du K, Syed A, Chen P. Human Gut Microbiome-Based Knowledgebase as a Biomarker Screening Tool to Improve the Predicted Probability for Colorectal Cancer. Front Microbiol 2020;11:596027. [PMID: 33329482 DOI: 10.3389/fmicb.2020.596027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Koulouris A, Tsagkaris C, Messaritakis I, Gouvas N, Sfakianaki M, Trypaki M, Spyrou V, Christodoulakis M, Athanasakis E, Xynos E, Tzardi M, Mavroudis D, Souglakos J. Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies. Cancers (Basel) 2021;13:3522. [PMID: 34298740 DOI: 10.3390/cancers13143522] [Reference Citation Analysis]
18 Wang K, Song M. Personalized nutrition for colorectal cancer. Adv Cancer Res 2021;151:109-36. [PMID: 34148612 DOI: 10.1016/bs.acr.2021.02.004] [Reference Citation Analysis]
19 Babakhanov AT, Dzhumabekov AT, Zhao AV, Kuandykov YK, Tanabayeva SB, Fakhradiyev IR, Nazarenko Y, Saliev TM. Impact of Appendectomy on Gut Microbiota. Surg Infect (Larchmt) 2021;22:651-61. [PMID: 33523761 DOI: 10.1089/sur.2020.422] [Reference Citation Analysis]
20 Bergsten E, Mestivier D, Sobhani I. The Limits and Avoidance of Biases in Metagenomic Analyses of Human Fecal Microbiota. Microorganisms 2020;8:E1954. [PMID: 33317070 DOI: 10.3390/microorganisms8121954] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Papantoniou K, Castaño-Vinyals G, Espinosa A, Turner MC, Martín-Sánchez V, Casabonne D, Aragonés N, Gómez-Acebo I, Ardanaz E, Jimenez-Moleon JJ, Amiano P, Molina-Barceló A, Alguacil J, Fernández-Tardón G, Huerta JM, Hernández-Segura N, Perez-Gomez B, Llorca J, Vidán-Alli J, Olmedo-Requena R, Gil L, Castañon-López C, Pollan M, Kogevinas M, Moreno V. Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study. Sci Rep 2021;11:11822. [PMID: 34083698 DOI: 10.1038/s41598-021-91275-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Marzullo P, Bettini S, Menafra D, Aprano S, Muscogiuri G, Barrea L, Savastano S, Colao A; Obesity Programs of nutrition, Education, Research and Assessment (OPERA) group. Spot-light on microbiota in obesity and cancer. Int J Obes (Lond) 2021. [PMID: 34363002 DOI: 10.1038/s41366-021-00866-7] [Reference Citation Analysis]
23 Kaźmierczak-Siedlecka K, Roviello G, Catalano M, Polom K. Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers. Nutrients 2021;13:2674. [PMID: 34444834 DOI: 10.3390/nu13082674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Sun Y, Cheng L, Zeng X, Zhang X, Liu Y, Wu Z, Weng P. The intervention of unique plant polysaccharides - Dietary fiber on depression from the gut-brain axis. Int J Biol Macromol 2021;170:336-42. [PMID: 33373637 DOI: 10.1016/j.ijbiomac.2020.12.164] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Patel A, Spychalski P, Antoszewska M, Regula J, Kobiela J. Proton pump inhibitors and colorectal cancer: A systematic review. World J Gastroenterol 2021; 27(44): 7716-7733 [PMID: 34908809 DOI: 10.3748/wjg.v27.i44.7716] [Reference Citation Analysis]
26 Biondi A, Basile F, Vacante M. Familial adenomatous polyposis and changes in the gut microbiota: New insights into colorectal cancer carcinogenesis. World J Gastrointest Oncol 2021; 13(6): 495-508 [PMID: 34163569 DOI: 10.4251/wjgo.v13.i6.495] [Reference Citation Analysis]
27 Rebersek M. Gut microbiome and its role in colorectal cancer. BMC Cancer 2021;21:1325. [PMID: 34895176 DOI: 10.1186/s12885-021-09054-2] [Reference Citation Analysis]
28 Leonard W, Zhang P, Ying D, Fang Z. Hydroxycinnamic acids on gut microbiota and health. Comprehensive Reviews in Food Science and Food Safety 2021;20:710-37. [DOI: 10.1111/1541-4337.12663] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Garcia-Etxebarria K, Clos-Garcia M, Telleria O, Nafría B, Alonso C, Iruarrizaga-Lejarreta M, Franke A, Crespo A, Iglesias A, Cubiella J, Bujanda L, Falcón-Pérez JM. Interplay between Genome, Metabolome and Microbiome in Colorectal Cancer. Cancers (Basel) 2021;13:6216. [PMID: 34944836 DOI: 10.3390/cancers13246216] [Reference Citation Analysis]
30 Li N, Zhang H, Bai Z, Jiang H, Yang F, Sun X, Lu Z, Zhou D. Soil exposure accelerates recovery of the gut microbiota in antibiotic-treated mice. Environ Microbiol Rep 2021. [PMID: 33982448 DOI: 10.1111/1758-2229.12959] [Reference Citation Analysis]
31 Hong J, Guo F, Lu SY, Shen C, Ma D, Zhang X, Xie Y, Yan T, Yu T, Sun T, Qian Y, Zhong M, Chen J, Peng Y, Wang C, Zhou X, Liu J, Liu Q, Ma X, Chen YX, Chen H, Fang JY. F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer. Gut 2020:gutjnl-2020-322780. [PMID: 33318144 DOI: 10.1136/gutjnl-2020-322780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
32 Gao ZY, Cui Z, Yan YQ, Ning LJ, Wang ZH, Hong J. Microbe-based management for colorectal cancer. Chin Med J (Engl) 2021;134:2922-30. [PMID: 34855639 DOI: 10.1097/CM9.0000000000001887] [Reference Citation Analysis]
33 Cione E, Fazio A, Curcio R, Tucci P, Lauria G, Cappello ARR, Dolce V. Resistant Starches and Non-Communicable Disease: A Focus on Mediterranean Diet. Foods 2021;10:2062. [PMID: 34574171 DOI: 10.3390/foods10092062] [Reference Citation Analysis]
34 Liu Y, Li X, Yang Y, Liu Y, Wang S, Ji B, Wei Y. Exploring Gut Microbiota in Patients with Colorectal Disease Based on 16S rRNA Gene Amplicon and Shallow Metagenomic Sequencing. Front Mol Biosci 2021;8:703638. [PMID: 34307461 DOI: 10.3389/fmolb.2021.703638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Cai C, Zhang X, Liu Y, Shen E, Feng Z, Guo C, Han Y, Ouyang Y, Shen H. Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality. Gut Pathog 2021;13:70. [PMID: 34863291 DOI: 10.1186/s13099-021-00466-w] [Reference Citation Analysis]
36 Zhang YK, Zhang Q, Wang YL, Zhang WY, Hu HQ, Wu HY, Sheng XZ, Luo KJ, Zhang H, Wang M, Huang R, Wang GY. A Comparison Study of Age and Colorectal Cancer-Related Gut Bacteria. Front Cell Infect Microbiol 2021;11:606490. [PMID: 33996615 DOI: 10.3389/fcimb.2021.606490] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Ge Y, Wang X, Guo Y, Yan J, Abuduwaili A, Aximujiang K, Yan J, Wu M. Gut microbiota influence tumor development and Alter interactions with the human immune system. J Exp Clin Cancer Res 2021;40:42. [PMID: 33494784 DOI: 10.1186/s13046-021-01845-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
38 Li D, Gao C, Zhang F, Yang R, Lan C, Ma Y, Wang J. Seven facts and five initiatives for gut microbiome research. Protein Cell. 2020;11:391-400. [PMID: 32172500 DOI: 10.1007/s13238-020-00697-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Alkharaan H, Lu L, Gabarrini G, Halimi A, Ateeb Z, Sobkowiak MJ, Davanian H, Fernández Moro C, Jansson L, Del Chiaro M, Özenci V, Sällberg Chen M. Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy. Front Immunol 2020;11:2003. [PMID: 32983143 DOI: 10.3389/fimmu.2020.02003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
40 Feng X, Han L, Ma S, Zhao L, Wang L, Zhang K, Yin P, Guo L, Jing W, Li Q. Microbes in Tumoral In Situ Tissues and in Tumorigenesis. Front Cell Infect Microbiol 2020;10:572570. [PMID: 33330121 DOI: 10.3389/fcimb.2020.572570] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio ME, Jimenez-Rodriguez B, Lavado R, Comino-Méndez I, Alba E, Queipo-Ortuño MI. Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment. Cancers (Basel) 2020;12:E2465. [PMID: 32878124 DOI: 10.3390/cancers12092465] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
42 Lee MH. Harness the functions of gut microbiome in tumorigenesis for cancer treatment. Cancer Commun (Lond) 2021. [PMID: 34355542 DOI: 10.1002/cac2.12200] [Reference Citation Analysis]
43 Saeed M, Shoaib A, Kandimalla R, Javed S, Almatroudi A, Gupta R, Aqil F. Microbe-based therapies for colorectal cancer: Advantages and limitations. Semin Cancer Biol 2021:S1044-579X(21)00148-6. [PMID: 34020027 DOI: 10.1016/j.semcancer.2021.05.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 de Souza JB, Brelaz-de-Castro MCA, Cavalcanti IMF. Strategies for the treatment of colorectal cancer caused by gut microbiota. Life Sci 2021;290:120202. [PMID: 34896161 DOI: 10.1016/j.lfs.2021.120202] [Reference Citation Analysis]
45 Tao ZH, Han JX, Fang JY. Helicobacter pylori infection and eradication: Exploring their impacts on the gastrointestinal microbiota. Helicobacter 2020;25:e12754. [PMID: 32876377 DOI: 10.1111/hel.12754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
46 Xia Y. Correlation and association analyses in microbiome study integrating multiomics in health and disease. Prog Mol Biol Transl Sci 2020;171:309-491. [PMID: 32475527 DOI: 10.1016/bs.pmbts.2020.04.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Yang M, Zhang Q, Ruan GT, Tang M, Zhang X, Song MM, Zhang XW, Zhang KP, Ge YZ, Shi HP. Association Between Serum Creatinine Concentrations and Overall Survival in Patients With Colorectal Cancer: A Multi-Center Cohort Study. Front Oncol 2021;11:710423. [PMID: 34692487 DOI: 10.3389/fonc.2021.710423] [Reference Citation Analysis]
48 Tokuhara D. Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents. Front Nutr 2021;8:700058. [PMID: 34250000 DOI: 10.3389/fnut.2021.700058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Li Y, Li ZX, Xie CY, Fan J, Lv J, Xu XJ, Lv J, Kuai WT, Jia YT. Gegen Qinlian decoction enhances immunity and protects intestinal barrier function in colorectal cancer patients via gut microbiota. World J Gastroenterol 2020; 26(48): 7633-7651 [PMID: 33505141 DOI: 10.3748/wjg.v26.i48.7633] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Walrath T, Dyamenahalli KU, Hulsebus HJ, McCullough RL, Idrovo JP, Boe DM, McMahan RH, Kovacs EJ. Age-related changes in intestinal immunity and the microbiome. J Leukoc Biol 2021;109:1045-61. [PMID: 33020981 DOI: 10.1002/JLB.3RI0620-405RR] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Whiteside SA, McGinniss JE, Collman RG. The lung microbiome: progress and promise. J Clin Invest 2021;131:150473. [PMID: 34338230 DOI: 10.1172/JCI150473] [Reference Citation Analysis]
52 Wiciński M, Gębalski J, Gołębiewski J, Malinowski B. Probiotics for the Treatment of Overweight and Obesity in Humans-A Review of Clinical Trials. Microorganisms 2020;8:E1148. [PMID: 32751306 DOI: 10.3390/microorganisms8081148] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
53 Coker OO, Wu WKK, Wong SH, Sung JJY, Yu J. Altered Gut Archaea Composition and Interaction With Bacteria Are Associated With Colorectal Cancer. Gastroenterology 2020; 159: 1459-1470. e5. [PMID: 32569776 DOI: 10.1053/j.gastro.2020.06.042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
54 Andrei P, Battuello P, Grasso G, Rovera E, Tesio N, Bardelli A. Integrated approaches for precision oncology in colorectal cancer: The more you know, the better. Semin Cancer Biol 2021:S1044-579X(21)00108-5. [PMID: 33848627 DOI: 10.1016/j.semcancer.2021.04.007] [Reference Citation Analysis]
55 Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther 2020;5:22. [PMID: 32296018 DOI: 10.1038/s41392-020-0116-z] [Cited by in Crossref: 130] [Cited by in F6Publishing: 140] [Article Influence: 65.0] [Reference Citation Analysis]
56 Zeng T, Yu X, Chen Z. Applying artificial intelligence in the microbiome for gastrointestinal diseases: A review. J Gastroenterol Hepatol 2021;36:832-40. [PMID: 33880762 DOI: 10.1111/jgh.15503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Ye GY, Zhang ZZ, Zhu CC, Cong ZJ, Cui Z, Chen L, Zhao G. Long Non-Coding RNA LINC01569 Promotes Proliferation and Metastasis in Colorectal Cancer by miR-381-3p/RAP2A Axis. Front Oncol 2021;11:727698. [PMID: 34422671 DOI: 10.3389/fonc.2021.727698] [Reference Citation Analysis]
58 Hu WH, Yang WC, Liu PF, Liu TT, Morgan P, Tsai WL, Pan HW, Lee CH, Shu CW. Clinicopathological Association of Autophagy Related 5 Protein with Prognosis of Colorectal Cancer. Diagnostics (Basel) 2021;11:782. [PMID: 33926066 DOI: 10.3390/diagnostics11050782] [Reference Citation Analysis]
59 Qin X, Gu Y, Liu T, Wang C, Zhong W, Wang B, Cao H. Gut mycobiome: A promising target for colorectal cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188489. [PMID: 33278512 DOI: 10.1016/j.bbcan.2020.188489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
60 Kamareddine L, Najjar H, Sohail MU, Abdulkader H, Al-Asmakh M. The Microbiota and Gut-Related Disorders: Insights from Animal Models. Cells 2020;9:E2401. [PMID: 33147801 DOI: 10.3390/cells9112401] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
61 Rampelli S, Fabbrini M, Candela M, Biagi E, Brigidi P, Turroni S. G2S: A New Deep Learning Tool for Predicting Stool Microbiome Structure From Oral Microbiome Data. Front Genet 2021;12:644516. [PMID: 33897763 DOI: 10.3389/fgene.2021.644516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Perillo F, Amoroso C, Strati F, Giuffrè MR, Díaz-Basabe A, Lattanzi G, Facciotti F. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes. Int J Mol Sci 2020;21:E5389. [PMID: 32751239 DOI: 10.3390/ijms21155389] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
63 Park YY, Lee KY, Oh ST, Park SH, Han KD, Lee J. A link between appendectomy and gastrointestinal cancers: a large-scale population-based cohort study in Korea. Sci Rep 2020;10:15670. [PMID: 32973258 DOI: 10.1038/s41598-020-72770-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Liu W, Zhang X, Xu H, Li S, Lau HC, Chen Q, Zhang B, Zhao L, Chen H, Sung JJ, Yu J. Microbial Community Heterogeneity Within Colorectal Neoplasia and its Correlation With Colorectal Carcinogenesis. Gastroenterology 2021;160:2395-408. [PMID: 33581124 DOI: 10.1053/j.gastro.2021.02.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
65 Sulżyc-Bielicka V, Kołodziejczyk L, Adamska M, Skotarczak B, Jaczewska S, Safranow K, Bielicki P, Kładny J, Bielicki D. Colorectal cancer and Blastocystis sp. infection. Parasit Vectors 2021;14:200. [PMID: 33853659 DOI: 10.1186/s13071-021-04681-x] [Reference Citation Analysis]
66 Parisi A, Porzio G, Pulcini F, Cannita K, Ficorella C, Mattei V, Delle Monache S. What Is Known about Theragnostic Strategies in Colorectal Cancer. Biomedicines 2021;9:140. [PMID: 33535557 DOI: 10.3390/biomedicines9020140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Amedei A, Capasso C, Nannini G, Supuran CT. Microbiota, Bacterial Carbonic Anhydrases, and Modulators of Their Activity: Links to Human Diseases? Mediators Inflamm 2021;2021:6926082. [PMID: 34803517 DOI: 10.1155/2021/6926082] [Reference Citation Analysis]
68 Nascimento FSD, Suzuki MO, Taba JV, de Mattos VC, Pipek LZ, D'Albuquerque EMC, Iuamoto L, Meyer A, Andraus W, Pinho JRR, de Moura EGH, Setubal JC, Carneiro-D'Albuquerque LA. Analysis of biliary MICRObiota in hepatoBILIOpancreatic diseases compared to healthy people [MICROBILIO]: Study protocol. PLoS One 2020;15:e0242553. [PMID: 33211762 DOI: 10.1371/journal.pone.0242553] [Reference Citation Analysis]
69 Chen S, Zheng Y, Ran X, Du H, Feng H, Yang L, Wen Y, Lin C, Wang S, Huang M, Yan Z, Wu D, Wang H, Ge G, Zeng A, Zeng YA, Chen J. Integrin αEβ7+ T cells direct intestinal stem cell fate decisions via adhesion signaling. Cell Res 2021. [PMID: 34518654 DOI: 10.1038/s41422-021-00561-2] [Reference Citation Analysis]
70 Xia DM, Wang XR, Zhou PY, Ou TL, Su L, Xu SG. Research progress of heat stroke during 1989-2019: a bibliometric analysis. Mil Med Res 2021;8:5. [PMID: 33472705 DOI: 10.1186/s40779-021-00300-z] [Reference Citation Analysis]
71 Huang HC, Cai BH, Suen CS, Lee HY, Hwang MJ, Liu FT, Kannagi R. BGN/TLR4/NF-B Mediates Epigenetic Silencing of Immunosuppressive Siglec Ligands in Colon Cancer Cells. Cells 2020;9:E397. [PMID: 32050430 DOI: 10.3390/cells9020397] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
72 Yoha KS, Nida S, Dutta S, Moses JA, Anandharamakrishnan C. Targeted Delivery of Probiotics: Perspectives on Research and Commercialization. Probiotics Antimicrob Proteins 2021. [PMID: 33904011 DOI: 10.1007/s12602-021-09791-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Mohammadi M, Mirzaei H, Motallebi M. The role of anaerobic bacteria in the development and prevention of colorectal cancer: A review study. Anaerobe 2021;73:102501. [PMID: 34906686 DOI: 10.1016/j.anaerobe.2021.102501] [Reference Citation Analysis]
74 Wang T, Wang P, Ge W, Shi C, Xiao G, Wang X, Lü X. The probiotic Companilactobacillus crustorum MN047 alleviates colitis-associated tumorigenesis via modulating the intestinal microenvironment. Food Funct 2021;12:11331-42. [PMID: 34668003 DOI: 10.1039/d1fo01531a] [Reference Citation Analysis]
75 Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, Przybyłowicz KE. A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers (Basel) 2021;13:2025. [PMID: 33922197 DOI: 10.3390/cancers13092025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
76 Yuan Y, Chen Y, Yao F, Zeng M, Xie Q, Shafiq M, Noman SM, Jiao X. Microbiomes and Resistomes in Biopsy Tissue and Intestinal Lavage Fluid of Colorectal Cancer. Front Cell Dev Biol 2021;9:736994. [PMID: 34604238 DOI: 10.3389/fcell.2021.736994] [Reference Citation Analysis]
77 Niccolai E, Russo E, Baldi S, Ricci F, Nannini G, Pedone M, Stingo FC, Taddei A, Ringressi MN, Bechi P, Mengoni A, Fani R, Bacci G, Fagorzi C, Chiellini C, Prisco D, Ramazzotti M, Amedei A. Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer. Front Immunol 2020;11:573158. [PMID: 33488574 DOI: 10.3389/fimmu.2020.573158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Li Q, Hu W, Liu WX, Zhao LY, Huang D, Liu XD, Chan H, Zhang Y, Zeng JD, Coker OO, Kang W, Ng SSM, Zhang L, Wong SH, Gin T, Chan MTV, Wu JL, Yu J, Wu WKK. Streptococcus thermophilus Inhibits Colorectal Tumorigenesis Through Secreting β-Galactosidase. Gastroenterology 2021;160:1179-1193.e14. [PMID: 32920015 DOI: 10.1053/j.gastro.2020.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
79 Panneerselvam J, Madka V, Rai R, Morris KT, Houchen CW, Chandrakesan P, Rao CV. Inflammatory Mediators and Gut Microbial Toxins Drive Colon Tumorigenesis by IL-23 Dependent Mechanism. Cancers (Basel) 2021;13:5159. [PMID: 34680308 DOI: 10.3390/cancers13205159] [Reference Citation Analysis]
80 Abancens M, Bustos V, Harvey H, McBryan J, Harvey BJ. Sexual Dimorphism in Colon Cancer. Front Oncol 2020;10:607909. [PMID: 33363037 DOI: 10.3389/fonc.2020.607909] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Tong Y, Gao H, Qi Q, Liu X, Li J, Gao J, Li P, Wang Y, Du L, Wang C. High fat diet, gut microbiome and gastrointestinal cancer. Theranostics 2021;11:5889-910. [PMID: 33897888 DOI: 10.7150/thno.56157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Mann EH, Maughan TS. Fusobacterium nucleatum, rectal cancer and radiotherapy. Ann Oncol 2020;31:1277-8. [PMID: 32629022 DOI: 10.1016/j.annonc.2020.06.019] [Reference Citation Analysis]
83 Peng Y, Nie Y, Yu J, Wong CC. Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications. Metabolites 2021;11:159. [PMID: 33802045 DOI: 10.3390/metabo11030159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Luo L, Chen Q, Yang L, Zhang Z, Xu J, Gou D. MSCs Therapy Reverse the Gut Microbiota in Hypoxia-Induced Pulmonary Hypertension Mice. Front Physiol 2021;12:712139. [PMID: 34531759 DOI: 10.3389/fphys.2021.712139] [Reference Citation Analysis]
85 Zhao R, Coker OO, Wu J, Zhou Y, Zhao L, Nakatsu G, Bian X, Wei H, Chan AWH, Sung JJY, Chan FKL, El-Omar E, Yu J. Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects. Gastroenterology. 2020;159:969-983.e4. [PMID: 32387495 DOI: 10.1053/j.gastro.2020.05.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
86 Zhou CB, Zhou YL, Fang JY. Gut Microbiota in Cancer Immune Response and Immunotherapy. Trends Cancer 2021;7:647-60. [PMID: 33674230 DOI: 10.1016/j.trecan.2021.01.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
87 Veziant J, Villéger R, Barnich N, Bonnet M. Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer. Cancers (Basel) 2021;13:2215. [PMID: 34063108 DOI: 10.3390/cancers13092215] [Reference Citation Analysis]
88 Porter RJ, Murray GI, Alnabulsi A, Humphries MP, James JA, Salto-Tellez M, Craig SG, Wang JM, Yoshimura T, McLean MH. Colonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate. J Pathol Clin Res 2021;7:495-506. [PMID: 33988317 DOI: 10.1002/cjp2.222] [Reference Citation Analysis]
89 Pan S, Bao D, Li Y, Liu D, Quan S, Wang R. SOX4 induces drug resistance of colorectal cancer cells by downregulating CYLD through transcriptional activation of microRNA-17. J Biochem Mol Toxicol 2021;:e22910. [PMID: 34927777 DOI: 10.1002/jbt.22910] [Reference Citation Analysis]
90 Jaye K, Li CG, Bhuyan DJ. The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses. Crit Rev Oncol Hematol 2021;165:103429. [PMID: 34293459 DOI: 10.1016/j.critrevonc.2021.103429] [Reference Citation Analysis]
91 Kalasabail S, Engelman J, Zhang LY, El-Omar E, Yim HCH. A Perspective on the Role of Microbiome for Colorectal Cancer Treatment. Cancers (Basel) 2021;13:4623. [PMID: 34572850 DOI: 10.3390/cancers13184623] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Xing S, Wang Y, Hu K, Wang F, Sun T, Li Q. WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11. Biosci Rep 2020;40:BSR20200935. [PMID: 32812032 DOI: 10.1042/BSR20200935] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
93 Xu F, Fu Y, Sun TY, Jiang Z, Miao Z, Shuai M, Gou W, Ling CW, Yang J, Wang J, Chen YM, Zheng JS. The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for complex human diseases. Microbiome 2020;8:145. [PMID: 33032658 DOI: 10.1186/s40168-020-00923-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
94 Li G, Zhang T, Huang K, Zhu Y, Xu K, Gu J, Huang S, Gu C, Zhan R, Shen J. Long noncoding RNA GAS8-AS1: A novel biomarker in human diseases. Biomed Pharmacother 2021;139:111572. [PMID: 33838502 DOI: 10.1016/j.biopha.2021.111572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Peng C, Ouyang Y, Lu N, Li N. The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances. Front Immunol 2020;11:1387. [PMID: 32695120 DOI: 10.3389/fimmu.2020.01387] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
96 Song W, Chen Z, Zheng Z, Zhang Z, Chen Y, He X, Lan P, Hu J, He X. Risk factors for metachronous adenoma in patients with stage I/II colorectal cancer after radical surgery. J Gastrointest Oncol 2021;12:535-43. [PMID: 34012647 DOI: 10.21037/jgo-20-386] [Reference Citation Analysis]
97 Garajová I, Balsano R, Wang H, Leonardi F, Giovannetti E, Deng D, Peters GJ. The role of the microbiome in drug resistance in gastrointestinal cancers. Expert Rev Anticancer Ther 2021;21:165-76. [PMID: 33115280 DOI: 10.1080/14737140.2021.1844007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
98 Zhong M, Xiong Y, Ye Z, Zhao J, Zhong L, Liu Y, Zhu Y, Tian L, Qiu X, Hong X. Microbial Community Profiling Distinguishes Left-Sided and Right-Sided Colon Cancer. Front Cell Infect Microbiol 2020;10:498502. [PMID: 33324571 DOI: 10.3389/fcimb.2020.498502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Jasemi S, Emaneini M, Fazeli MS, Ahmadinejad Z, Nomanpour B, Sadeghpour Heravi F, Sechi LA, Feizabadi MM. Toxigenic and non-toxigenic patterns I, II and III and biofilm-forming ability in Bacteroides fragilis strains isolated from patients diagnosed with colorectal cancer. Gut Pathog 2020;12:28. [PMID: 32518594 DOI: 10.1186/s13099-020-00366-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Sphyris N, Hodder MC, Sansom OJ. Subversion of Niche-Signalling Pathways in Colorectal Cancer: What Makes and Breaks the Intestinal Stem Cell. Cancers (Basel) 2021;13:1000. [PMID: 33673710 DOI: 10.3390/cancers13051000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
101 Chen QW, Qiao JY, Liu XH, Zhang C, Zhang XZ. Customized materials-assisted microorganisms in tumor therapeutics. Chem Soc Rev 2021;50:12576-615. [PMID: 34605834 DOI: 10.1039/d0cs01571g] [Reference Citation Analysis]
102 Mori G, Pasca MR. Gut Microbial Signatures in Sporadic and Hereditary Colorectal Cancer. Int J Mol Sci 2021;22:1312. [PMID: 33525662 DOI: 10.3390/ijms22031312] [Reference Citation Analysis]
103 Lu K, Dong S, Wu X, Jin R, Chen H. Probiotics in Cancer. Front Oncol 2021;11:638148. [PMID: 33791223 DOI: 10.3389/fonc.2021.638148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 Bisht V, Nash K, Xu Y, Agarwal P, Bosch S, Gkoutos GV, Acharjee A. Integration of the Microbiome, Metabolome and Transcriptomics Data Identified Novel Metabolic Pathway Regulation in Colorectal Cancer. Int J Mol Sci 2021;22:5763. [PMID: 34071236 DOI: 10.3390/ijms22115763] [Reference Citation Analysis]
105 Durán-Vinet B, Araya-Castro K, Calderón J, Vergara L, Weber H, Retamales J, Araya-Castro P, Leal-Rojas P. CRISPR/Cas13-Based Platforms for a Potential Next-Generation Diagnosis of Colorectal Cancer through Exosomes Micro-RNA Detection: A Review. Cancers (Basel) 2021;13:4640. [PMID: 34572866 DOI: 10.3390/cancers13184640] [Reference Citation Analysis]
106 Tang G, Zhang L. Update on Strategies of Probiotics for the Prevention and Treatment of Colorectal Cancer. Nutr Cancer 2020;:1-12. [PMID: 33356609 DOI: 10.1080/01635581.2020.1865420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 Sui H, Zhang L, Gu K, Chai N, Ji Q, Zhou L, Wang Y, Ren J, Yang L, Zhang B, Hu J, Li Q. YYFZBJS ameliorates colorectal cancer progression in ApcMin/+ mice by remodeling gut microbiota and inhibiting regulatory T-cell generation. Cell Commun Signal 2020;18:113. [PMID: 32677955 DOI: 10.1186/s12964-020-00596-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
108 Tangestani H, Salari-Moghaddam A, Ghalandari H, Emamat H. Adherence to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern reduces the risk of colorectal cancer: A systematic review and meta-analysis. Clin Nutr 2020;39:2975-81. [PMID: 32063407 DOI: 10.1016/j.clnu.2020.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
109 Hemmati M, Yousefi B, Bahar A, Eslami M. Importance of Heme Oxygenase-1 in Gastrointestinal Cancers: Functions, Inductions, Regulations, and Signaling. J Gastrointest Cancer 2021;52:454-61. [PMID: 33484436 DOI: 10.1007/s12029-021-00587-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
110 Schonkeren SL, Thijssen MS, Vaes N, Boesmans W, Melotte V. The Emerging Role of Nerves and Glia in Colorectal Cancer. Cancers (Basel) 2021;13:E152. [PMID: 33466373 DOI: 10.3390/cancers13010152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
111 Simin J, Tamimi RM, Engstrand L, Callens S, Brusselaers N. Antibiotic use and the risk of breast cancer: A systematic review and dose-response meta-analysis. Pharmacol Res 2020;160:105072. [PMID: 32679181 DOI: 10.1016/j.phrs.2020.105072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
112 Gu Y, Yan D, Wu M, Li M, Li P, Wang J, Chang Y, Yang F, Di S, Ni S, Yang M, Liu J. Influence of the densities and nutritional components of bacterial colonies on the culture-enriched gut bacterial community structure. AMB Express 2021;11:78. [PMID: 34057622 DOI: 10.1186/s13568-021-01240-6] [Reference Citation Analysis]
113 Yang J, Wei H, Zhou Y, Szeto CH, Li C, Lin Y, Coker OO, Hay Lau HC, Chan AWH, Sung JJY, Yu J. High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites. Gastroenterology 2021:S0016-5085(21)03439-9. [PMID: 34461052 DOI: 10.1053/j.gastro.2021.08.041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
114 Shao S, Jia R, Zhao L, Zhang Y, Guan Y, Wen H, Liu J, Zhao Y, Feng Y, Zhang Z, Ji Q, Li Q, Wang Y. Xiao-Chai-Hu-Tang ameliorates tumor growth in cancer comorbid depressive symptoms via modulating gut microbiota-mediated TLR4/MyD88/NF-κB signaling pathway. Phytomedicine 2021;88:153606. [PMID: 34111616 DOI: 10.1016/j.phymed.2021.153606] [Reference Citation Analysis]
115 Xie X, Jiang D, Zhou X, Ye X, Yang P, He Y. Recombinant Bacteroides fragilis enterotoxin-1 (rBFT-1) promotes proliferation of colorectal cancer via CCL3-related molecular pathways. Open Life Sci 2021;16:408-18. [PMID: 33981848 DOI: 10.1515/biol-2021-0043] [Reference Citation Analysis]
116 Rebersek M. Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision. Radiol Oncol 2020;54:272-7. [PMID: 32463385 DOI: 10.2478/raon-2020-0031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
117 Ahmad Kendong SM, Raja Ali RA, Nawawi KNM, Ahmad HF, Mokhtar NM. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer. Front Cell Infect Microbiol 2021;11:744606. [PMID: 34966694 DOI: 10.3389/fcimb.2021.744606] [Reference Citation Analysis]
118 Koulouridi A, Messaritakis I, Theodorakis E, Chondrozoumaki M, Sfakianaki M, Gouvas N, Tsiaoussis J, Mavroudis D, Tzardi M, Souglakos J. Detection of Circulating Tumor Cells and Microbial DNA Fragments in Stage III Colorectal Cancer Patients under Three versus Six Months of Adjuvant Treatment. Cancers (Basel) 2021;13:3552. [PMID: 34298766 DOI: 10.3390/cancers13143552] [Reference Citation Analysis]
119 Pin-Vieito N, Tejido-Sandoval C, de Vicente-Bielza N, Sánchez-Gómez C, Cubiella J. Faecal immunochemical tests safely enhance rational use of resources during the assessment of suspected symptomatic colorectal cancer in primary care: systematic review and meta-analysis. Gut 2021:gutjnl-2021-324856. [PMID: 34108236 DOI: 10.1136/gutjnl-2021-324856] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Lu J, Zhang L, Zhai Q, Zhao J, Zhang H, Lee YK, Lu W, Li M, Chen W. Chinese gut microbiota and its associations with staple food type, ethnicity, and urbanization. NPJ Biofilms Microbiomes 2021;7:71. [PMID: 34489454 DOI: 10.1038/s41522-021-00245-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Gao J, Yin J, Xu K, Han H, Liu Z, Wang C, Li T, Yin Y. Protein Level and Infantile Diarrhea in a Postweaning Piglet Model. Mediators Inflamm 2020;2020:1937387. [PMID: 32565721 DOI: 10.1155/2020/1937387] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Zhu Z, Huang J, Li X, Xing J, Chen Q, Liu R, Hua F, Qiu Z, Song Y, Bai C, Mo YY, Zhang Z. Gut microbiota regulate tumor metastasis via circRNA/miRNA networks. Gut Microbes. 2020;12:1788891. [PMID: 32686598 DOI: 10.1080/19490976.2020.1788891] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
123 Yu TC, Zhou YL, Fang JY. Oral pathogen in the pathogenesis of colorectal cancer. J Gastroenterol Hepatol 2021. [PMID: 34837266 DOI: 10.1111/jgh.15743] [Reference Citation Analysis]
124 Okumura S, Konishi Y, Narukawa M, Sugiura Y, Yoshimoto S, Arai Y, Sato S, Yoshida Y, Tsuji S, Uemura K, Wakita M, Matsudaira T, Matsumoto T, Kawamoto S, Takahashi A, Itatani Y, Miki H, Takamatsu M, Obama K, Takeuchi K, Suematsu M, Ohtani N, Fukunaga Y, Ueno M, Sakai Y, Nagayama S, Hara E. Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion. Nat Commun 2021;12:5674. [PMID: 34584098 DOI: 10.1038/s41467-021-25965-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
125 Debesa-Tur G, Pérez-Brocal V, Ruiz-Ruiz S, Castillejo A, Latorre A, Soto JL, Moya A. Metagenomic analysis of formalin-fixed paraffin-embedded tumor and normal mucosa reveals differences in the microbiome of colorectal cancer patients. Sci Rep 2021;11:391. [PMID: 33432015 DOI: 10.1038/s41598-020-79874-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
126 Cheung MK, Yue GGL, Chiu PWY, Lau CBS. A Review of the Effects of Natural Compounds, Medicinal Plants, and Mushrooms on the Gut Microbiota in Colitis and Cancer. Front Pharmacol 2020;11:744. [PMID: 32499711 DOI: 10.3389/fphar.2020.00744] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
127 Wu Y, Jiao N, Zhu R, Zhang Y, Wu D, Wang AJ, Fang S, Tao L, Li Y, Cheng S, He X, Lan P, Tian C, Liu NN, Zhu L. Identification of microbial markers across populations in early detection of colorectal cancer. Nat Commun 2021;12:3063. [PMID: 34031391 DOI: 10.1038/s41467-021-23265-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Janney A, Powrie F, Mann EH. Host–microbiota maladaptation in colorectal cancer. Nature 2020;585:509-17. [DOI: 10.1038/s41586-020-2729-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 17.0] [Reference Citation Analysis]
129 Brüggemann H, Al-Zeer MA. Bacterial signatures and their inflammatory potentials associated with prostate cancer. APMIS 2020;128:80-91. [PMID: 31990107 DOI: 10.1111/apm.13021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
130 Weglarz-Tomczak E, Tomczak JM, Brul S. M2R: a Python add-on to cobrapy for modifying human genome-scale metabolic reconstruction using the gut microbiota models. Bioinformatics 2021:btab060. [PMID: 33523116 DOI: 10.1093/bioinformatics/btab060] [Reference Citation Analysis]
131 Ding S, Xu S, Fang J, Jiang H. The Protective Effect of Polyphenols for Colorectal Cancer. Front Immunol 2020;11:1407. [PMID: 32754151 DOI: 10.3389/fimmu.2020.01407] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
132 Oba S, Sunagawa T, Tanihiro R, Awashima K, Sugiyama H, Odani T, Nakamura Y, Kondo A, Sasaki D, Sasaki K. Prebiotic effects of yeast mannan, which selectively promotes Bacteroides thetaiotaomicron and Bacteroides ovatus in a human colonic microbiota model. Sci Rep 2020;10:17351. [PMID: 33060635 DOI: 10.1038/s41598-020-74379-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
133 Arnesen H, Hitch TCA, Steppeler C, Müller MHB, Knutsen LE, Gunnes G, Angell IL, Ormaasen I, Rudi K, Paulsen JE, Clavel T, Carlsen H, Boysen P. Naturalizing laboratory mice by housing in a farmyard-type habitat confers protection against colorectal carcinogenesis. Gut Microbes 2021;13:1993581. [PMID: 34751603 DOI: 10.1080/19490976.2021.1993581] [Reference Citation Analysis]
134 Lau HCH, Kranenburg O, Xiao H, Yu J. Organoid models of gastrointestinal cancers in basic and translational research. Nat Rev Gastroenterol Hepatol 2020;17:203-22. [PMID: 32099092 DOI: 10.1038/s41575-019-0255-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 16.0] [Reference Citation Analysis]
135 Lu L, Liu YJ, Cheng PQ, Hu D, Xu HC, Ji G. Macrophages play a role in inflammatory transformation of colorectal cancer. World J Gastrointest Oncol 2021; 13(12): 2013-2028 [DOI: 10.4251/wjgo.v13.i12.2013] [Reference Citation Analysis]
136 Yu B, Wang L, Chu Y. Gut microbiota shape B cell in health and disease settings. J Leukoc Biol 2021;110:271-81. [PMID: 33974295 DOI: 10.1002/JLB.1MR0321-660R] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
137 Mima K, Kosumi K, Baba Y, Hamada T, Baba H, Ogino S. The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor-immune-microbiome interaction. Hum Genet 2021;140:725-46. [PMID: 33180176 DOI: 10.1007/s00439-020-02235-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
138 Huang X, Chen L, Li Z, Zheng B, Liu N, Fang Q, Jiang J, Rao T, Ouyang D. The efficacy and toxicity of antineoplastic antimetabolites: Role of gut microbiota. Toxicology 2021;460:152858. [PMID: 34273448 DOI: 10.1016/j.tox.2021.152858] [Reference Citation Analysis]
139 Kurt M, Yumuk Z. Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer. Sci Rep 2021;11:1608. [PMID: 33452405 DOI: 10.1038/s41598-021-81171-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
140 Hull MA. Nutritional prevention of colorectal cancer. Proc Nutr Soc 2021;80:59-64. [PMID: 32019626 DOI: 10.1017/S0029665120000051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
141 Ma T, Wu M, Jia S, Yang L. Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies. Int J Colorectal Dis 2020;35:2157-69. [DOI: 10.1007/s00384-020-03717-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
142 Cherkasova V, Kovalchuk O, Kovalchuk I. Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer. Cancers (Basel) 2021;13:4353. [PMID: 34503163 DOI: 10.3390/cancers13174353] [Reference Citation Analysis]
143 Puccini A, Battaglin F, Iaia ML, Lenz HJ, Salem ME. Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies. J Immunother Cancer 2020;8:e000404. [PMID: 32393474 DOI: 10.1136/jitc-2019-000404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
144 Hull MA, Rees CJ, Sharp L, Koo S. A risk-stratified approach to colorectal cancer prevention and diagnosis. Nat Rev Gastroenterol Hepatol. 2020;17:773-780. [PMID: 33067592 DOI: 10.1038/s41575-020-00368-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
145 Williams GM, Tapsell LC, O'Brien CL, Tosh SM, Barrett EM, Beck EJ. Gut microbiome responses to dietary intake of grain-based fibers with the potential to modulate markers of metabolic disease: a systematic literature review. Nutr Rev 2020:nuaa128. [PMID: 33369654 DOI: 10.1093/nutrit/nuaa128] [Reference Citation Analysis]
146 Fang CY, Chen JS, Hsu BM, Hussain B, Rathod J, Lee KH. Colorectal Cancer Stage-Specific Fecal Bacterial Community Fingerprinting of the Taiwanese Population and Underpinning of Potential Taxonomic Biomarkers. Microorganisms 2021;9:1548. [PMID: 34442626 DOI: 10.3390/microorganisms9081548] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Wang X, Li Y, Zhou H, Han N, Pan L, Yu C. Effect of Gambogic Acid on miR-199a-3p Expression and Cell Biological Behavior in Colorectal Cancer Cells. J Oncol 2021;2021:5140621. [PMID: 34484332 DOI: 10.1155/2021/5140621] [Reference Citation Analysis]
148 Zhang N, Hu X, Du Y, Du J. The role of miRNAs in colorectal cancer progression and chemoradiotherapy. Biomedicine & Pharmacotherapy 2021;134:111099. [DOI: 10.1016/j.biopha.2020.111099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
149 Shao J, Li Z, Gao Y, Zhao K, Lin M, Li Y, Wang S, Liu Y, Chen L. Construction of a "Bacteria-Metabolites" Co-Expression Network to Clarify the Anti-Ulcerative Colitis Effect of Flavonoids of Sophora flavescens Aiton by Regulating the "Host-Microbe" Interaction. Front Pharmacol 2021;12:710052. [PMID: 34721011 DOI: 10.3389/fphar.2021.710052] [Reference Citation Analysis]
150 Kuo YC, Yu LY, Wang HY, Chen MJ, Wu MS, Liu CJ, Lin YC, Shih SC, Hu KC. Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum. World J Gastrointest Oncol 2022; 14(1): 55-74 [DOI: 10.4251/wjgo.v14.i1.55] [Reference Citation Analysis]
151 Kang X, Zhang R, Kwong TN, Lui RN, Wu WK, Sung JJ, Yu J, Wong SH. Serrated neoplasia in the colorectum: gut microbiota and molecular pathways. Gut Microbes 2021;13:1-12. [PMID: 33382354 DOI: 10.1080/19490976.2020.1863135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
152 Shi W, Shen L, Zou W, Wang J, Yang J, Wang Y, Liu B, Xie L, Zhu J, Zhang Z. The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients-A Pilot Study. Front Cell Infect Microbiol 2020;10:562463. [PMID: 33363048 DOI: 10.3389/fcimb.2020.562463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
153 Li X, Liu Y, Wang Y, Li X, Liu X, Guo M, Tan Y, Qin X, Wang X, Jiang M. Sucralose Promotes Colitis-Associated Colorectal Cancer Risk in a Murine Model Along With Changes in Microbiota. Front Oncol 2020;10:710. [PMID: 32582527 DOI: 10.3389/fonc.2020.00710] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
154 Vacante M, Ciuni R, Basile F, Biondi A. Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence. Biomedicines. 2020;8. [PMID: 33182693 DOI: 10.3390/biomedicines8110489] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
155 Huang QY, Yao F, Zhou CR, Huang XY, Wang Q, Long H, Wu QM. Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes. World J Clin Cases 2020; 8(24): 6213-6228 [PMID: 33392303 DOI: 10.12998/wjcc.v8.i24.6213] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
156 Dos Santos Ramos A, Viana GCS, de Macedo Brigido M, Almeida JF. Neutrophil extracellular traps in inflammatory bowel diseases: Implications in pathogenesis and therapeutic targets. Pharmacol Res 2021;171:105779. [PMID: 34298111 DOI: 10.1016/j.phrs.2021.105779] [Reference Citation Analysis]
157 Simin J, Fornes R, Liu Q, Olsen RS, Callens S, Engstrand L, Brusselaers N. Antibiotic use and risk of colorectal cancer: a systematic review and dose-response meta-analysis. Br J Cancer 2020;123:1825-32. [PMID: 32968205 DOI: 10.1038/s41416-020-01082-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
158 Gao P, Huang X, Fang XY, Zheng H, Cai SL, Sun AJ, Zhao L, Zhang Y. Application of metabolomics in clinical and laboratory gastrointestinal oncology. World J Gastrointest Oncol 2021; 13(6): 536-549 [PMID: 34163571 DOI: 10.4251/wjgo.v13.i6.536] [Reference Citation Analysis]
159 Zhang L, Chu CQ. Gut Microbiota-Medication Interaction in Rheumatic Diseases. Front Immunol 2021;12:796865. [PMID: 34925383 DOI: 10.3389/fimmu.2021.796865] [Reference Citation Analysis]
160 Zaborowski AM, Abdile A, Adamina M, Aigner F, d'Allens L, Allmer C, Álvarez A, Anula R, Andric M, Atallah S, Bach S, Bala M, Barussaud M, Bausys A, Bebington B, Beggs A, Bellolio F, Bennett MR, Berdinskikh A, Bevan V, Biondo S, Bislenghi G, Bludau M, Boutall A, Brouwer N, Brown C, Bruns C, Buchanan DD, Buchwald P, Burger JWA, Burlov N, Campanelli M, Capdepont M, Carvello M, Chew HH, Christoforidis D, Clark D, Climent M, Cologne KG, Contreras T, Croner R, Daniels IR, Dapri G, Davies J, Delrio P, Denost Q, Deutsch M, Dias A, D'Hoore A, Drozdov E, Duek D, Dunlop M, Dziki A, Edmundson A, Efetov S, El-Hussuna A, Elliot B, Emile S, Espin E, Evans M, Faes S, Faiz O, Fleming F, Foppa C, Fowler G, Frasson M, Figueiredo N, Forgan T, Frizelle F, Gadaev S, Gellona J, Glyn T, Gong J, Goran B, Greenwood E, Guren MG, Guillon S, Gutlic I, Hahnloser D, Hampel H, Hanly A, Hasegawa H, Iversen LH, Hill A, Hill J, Hoch J, Hoffmeister M, Hompes R, Hurtado L, Iaquinandi F, Imbrasaite U, Islam R, Jafari MD, Kanemitsu Y, Karachun A, Karimuddin AA, Keller DS, Kelly J, Kennelly R, Khrykov G, Kocian P, Koh C, Kok N, Knight KA, Knol J, Kontovounisios C, Korner H, Krivokapic Z, Kronberger I, Kroon HM, Kryzauskas M, Kural S, Kusters M, Lakkis Z, Lankov T, Larson D, Lázár G, Lee KY, Lee SH, Lefèvre JH, Lepisto A, Lieu C, Loi L, Lynch C, Maillou-Martinaud H, Maroli A, Martin S, Martling A, Matzel KE, Mayol J, McDermott F, Meurette G, Millan M, Mitteregger M, Moiseenko A, Monson JRT, Morarasu S, Moritani K, Möslein G, Munini M, Nahas C, Nahas S, Negoi I, Novikova A, Ocares M, Okabayashi K, Olkina A, Oñate-Ocaña L, Otero J, Ozen C, Pace U, São Julião GP, Panaiotti L, Panis Y, Papamichael D, Park J, Patel S, Patrón Uriburu JC, Pera M, Perez RO, Petrov A, Pfeffer F, Phang PT, Poskus T, Pringle H, Proud D, Raguz I, Rama N, Rasheed S, Raval MJ, Rega D, Reissfelder C, Reyes Meneses JC, Ris F, Riss S, Rodriguez-Zentner H, Roxburgh CS, Saklani A, Salido AJ, Sammour T, Saraste D, Schneider M, Seishima R, Sekulic A, Seppala T, Sheahan K, Shine R, Shlomina A, Sica GS, Singnomklao T, Siragusa L, Smart N, Solis A, Spinelli A, Staiger RD, Stamos MJ, Steele S, Sunderland M, Tan KK, Tanis PJ, Tekkis P, Teklay B, Tengku S, Jiménez-Toscano M, Tsarkov P, Turina M, Ulrich A, Vailati BB, van Harten M, Verhoef C, Warrier S, Wexner S, de Wilt H, Weinberg BA, Wells C, Wolthuis A, Xynos E, You N, Zakharenko A, Zeballos J, Winter DC; REACCT Collaborative. Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review. JAMA Surg 2021;156:865-74. [PMID: 34190968 DOI: 10.1001/jamasurg.2021.2380] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Yilmaz B, Ruckstuhl L, Müllhaupt B, Magenta L, Kuster MH, Clerc O, Torgler R, Semmo N. Pilot Sub-Study of the Effect of Hepatitis C Cure by Glecaprevir/Pibrentasvir on the Gut Microbiome of Patients with Chronic Hepatitis C Genotypes 1 to 6 in the Mythen Study. Pharmaceuticals (Basel) 2021;14:931. [PMID: 34577631 DOI: 10.3390/ph14090931] [Reference Citation Analysis]
162 Yang Y, Li L, Xu C, Wang Y, Wang Z, Chen M, Jiang Z, Pan J, Yang C, Li X, Song K, Yan J, Xie W, Wu X, Chen Z, Yuan Y, Zheng S, Yan J, Huang J, Qiu F. Cross-talk between the gut microbiota and monocyte-like macrophages mediates an inflammatory response to promote colitis-associated tumourigenesis. Gut 2020:gutjnl-2020-320777. [PMID: 33122176 DOI: 10.1136/gutjnl-2020-320777] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
163 Foegeding NJ, Byndloss MX. TAKing on cancer. Cell Host Microbe 2021;29:851-3. [PMID: 34111391 DOI: 10.1016/j.chom.2021.05.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
164 Heo G, Lee Y, Im E. Interplay between the Gut Microbiota and Inflammatory Mediators in the Development of Colorectal Cancer. Cancers (Basel) 2021;13:734. [PMID: 33578830 DOI: 10.3390/cancers13040734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
165 Hussain Z, El-Omar E, Lee YY. Dual infective burden of Helicobacter pylori and intestinal parasites: Good or bad news for the host? Indian J Gastroenterol 2020;39:111-6. [PMID: 32372188 DOI: 10.1007/s12664-020-01045-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
166 Ferretti E, Carlomagno S, Pesce S, Muccio L, Obino V, Greppi M, Solari A, Setti C, Marcenaro E, Della Chiesa M, Sivori S. Role of the Main Non HLA-Specific Activating NK Receptors in Pancreatic, Colorectal and Gastric Tumors Surveillance. Cancers (Basel) 2020;12:E3705. [PMID: 33321719 DOI: 10.3390/cancers12123705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
167 Joh HK, Lee DH, Hur J, Nimptsch K, Chang Y, Joung H, Zhang X, Rezende LFM, Lee JE, Ng K, Yuan C, Tabung FK, Meyerhardt JA, Chan AT, Pischon T, Song M, Fuchs CS, Willett WC, Cao Y, Ogino S, Giovannucci E, Wu K. Simple Sugar and Sugar-Sweetened Beverage Intake During Adolescence and Risk of Colorectal Cancer Precursors. Gastroenterology 2021;161:128-142.e20. [PMID: 33753105 DOI: 10.1053/j.gastro.2021.03.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
168 Lau HCH, Sung JJ, Yu J. Gut microbiota: impacts on gastrointestinal cancer immunotherapy. Gut Microbes 2021;13:1-21. [PMID: 33435800 DOI: 10.1080/19490976.2020.1869504] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
169 Lee JB, Kim KA, Cho HY, Kim D, Kim WK, Yong D, Lee H, Yoon SS, Han DH, Han YD, Paik S, Jang M, Kim HS, Ahn JB. Association between Fusobacterium nucleatum and patient prognosis in metastatic colon cancer. Sci Rep 2021;11:20263. [PMID: 34642332 DOI: 10.1038/s41598-021-98941-6] [Reference Citation Analysis]
170 Guo CG, Ma W, Drew DA, Cao Y, Nguyen LH, Joshi AD, Ng K, Ogino S, Meyerhardt JA, Song M, Leung WK, Giovannucci EL, Chan AT. Aspirin Use and Risk of Colorectal Cancer Among Older Adults. JAMA Oncol 2021;7:428-35. [PMID: 33475710 DOI: 10.1001/jamaoncol.2020.7338] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
171 Yao W, Jiao Y, Zhou Y, Luo X. KLF13 suppresses the proliferation and growth of colorectal cancer cells through transcriptionally inhibiting HMGCS1-mediated cholesterol biosynthesis. Cell Biosci 2020;10:76. [PMID: 32523679 DOI: 10.1186/s13578-020-00440-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
172 Wang Z, Hopson LM, Singleton SS, Yang X, Jogunoori W, Mazumder R, Obias V, Lin P, Nguyen BN, Yao M, Miller L, White J, Rao S, Mishra L. Mice with dysfunctional TGF-β signaling develop altered intestinal microbiome and colorectal cancer resistant to 5FU. Biochim Biophys Acta Mol Basis Dis 2021;1867:166179. [PMID: 34082069 DOI: 10.1016/j.bbadis.2021.166179] [Reference Citation Analysis]
173 Wang Q, Gong LM, Zheng H. Effects of live Clostridium butyricum tablets on intestinal flora balance, toxic and side effects, and immune inflammatory indexes in colorectal cancer patients on postoperative FOLFOX4 chemotherapy. Shijie Huaren Xiaohua Zazhi 2021; 29(8): 435-442 [DOI: 10.11569/wcjd.v29.i8.435] [Reference Citation Analysis]
174 Zhao DM, Diao YE, Xu Q. Association of MDM4 Gene rs4245739 Polymorphism with the Risk and Clinical Characteristics of Colorectal Cancer in a Chinese Han Population. Pharmgenomics Pers Med 2020;13:673-8. [PMID: 33273845 DOI: 10.2147/PGPM.S260209] [Reference Citation Analysis]
175 Zhang Y, Lu M, Lu B, Liu C, Ma Y, Liu L, Miao X, Qin J, Chen H, Dai M. Leveraging Fecal Microbial Markers to Improve the Diagnostic Accuracy of the Fecal Immunochemical Test for Advanced Colorectal Adenoma. Clin Transl Gastroenterol 2021;12:e00389. [PMID: 34408121 DOI: 10.14309/ctg.0000000000000389] [Reference Citation Analysis]